Nanotechnology Research Collaboration with Universidad de Sevilla to Create Time-Released Formulation for GB Sciences' THC-Free Chronic Pain Therapy

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Author(s): PR Newswire
  • Source:
    PR Newswire US. 10/10/2017.
  • Additional Information
    • Alternate Title:
      GBSCIENCES-Sevilla
    • Subject Terms:
      Nevada; Spain
    • Abstract:
      LAS VEGAS, Oct. 10, 2017 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) has entered into a Contract Research Agreement with the Universidad de Sevilla ("USE") to develop a time-released version of GB Sciences' proprietary, THC-free, myrcene-based chronic pain formulations. [ABSTRACT FROM PUBLISHER]